April 9, 2026 The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook
April 9, 2026 Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
April 9, 2026 STELLANTIS N.V. (STLA) INVESTOR ALERT Investors With Large Losses in Stellantis N.V. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
